Ginsenoside Rg3 inhibits CXCR 4 expression and related migrations in a breast cancer cell line

International Journal of Clinical Oncology

Volumn 16, Issue 5, 2011, Pages 519-523

  Chen, Xiao Ping ^a   Qian, Lin Lin ^a   Jiang, Hong ^b   Chen, Jiang Hua ^b  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Breast cancer; Chemotaxis; CXCR4; Mobility; Rg3

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; GINSENOSIDE RG 3; NATURAL PRODUCT; STROMAL CELL DERIVED FACTOR 1; ANTINEOPLASTIC AGENT; CXCR4 PROTEIN, HUMAN; GINSENOSIDE; HERBACEOUS AGENT;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL HOMING; CELL LINE; CELL MIGRATION; CELL STRAIN MDA MB 231; CHEMOTAXIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR; WOUND HEALING; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; CHEMOTAXIS; DRUGS, CHINESE HERBAL; FEMALE; GINSENOSIDES; HUMANS; RECEPTORS, CXCR4; WOUND HEALING;

EID: 84862882951     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0222-6     Document Type: Article

References (39)

1. Fishbein AB, Wang CZ, Li XL et al (2009) Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: comparison between white and red ginseng. Arch Pharm Res 32:505-513
2. Kim HS, Lee EH, Ko SR et al (2004) Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 27:429-435
3. Wang CZ, Aung HH, Zhang B et al (2008) Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Res 28:2545-2551
4. Xu TM, Cui MH, Xin Y et al (2008) Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin Med J 121:1394-1397
5. Lishi H, Tatsuta M, Baba M et al (1997) Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 15:603-611 (Pubitemid 27435741)
6. Chen J, Peng H, Ou-Yang X et al (2008) Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res 18:322-329
7. Yoo JH, Kwon HC, Kim YJ et al (2010) KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice. Cancer Lett 289:99-110
8. Xie JT, Wang CZ, Zhang B et al (2009) In vitro and in vivo anticancer effects of American ginseng berry: exploring representative compounds. Biol Pharm Bull 32:1552-1558
9. Liu TG, Huang Y, Cui DD et al (2009) Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogesis and growth of lung cancer in mice. BMC Cancer 23:250
10. Lee SY, Kim GT, Roh SH et al (2009) Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 73:811-816
11. Murphy PM (2001) Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345:833-835
12. Tse JC, Kalluri R (2007) Mechanisms of metastasis: epithelial- tomesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101:816-829 (Pubitemid 47040864)
13. Ben-Baruch A (2009) Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion. Cell Adh Migr 3:328-333
14. Hirakawa S (2009) From tumor lymphangiogenesis to lymphovascular niche. Cancer Sci 100:983-989
15. Müller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56 (Pubitemid 32225831)
16. Furusato B, Mohamed A, Uhlén M et al (2010) CXCR4 and cancer. Pathol Int 60:497-505
17. Hirbe AC, Morgan EA, Weibaecher KN (2010) The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastasis? Curr Pharm Des 16:1284-1290
18. Williams SA, Harata-Lee Y, Comerford I et al (2010) Multiple functions of CXCL12 in a syngeneic model of breast cancer. Mol Cancer 9:250-255
19. Byun HJ, Hong IK, Kim E et al (2006) A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways. J Biol Chem 281:34833-34847 (Pubitemid 46036523)
20. Yodkeeree S, Ampasavate C, Sung B et al (2010) Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol 627:8-15
21. Li H, Yang W, Chen PW et al (2009) Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases. Invest Ophthalmol Vis Sci 50:5522-5528
22. Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16:2927-2931
23. Chen X, Beutler JA, McCloud TG et al (2003) Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity. Clin Caner Res 9:3115-3123 (Pubitemid 36993274)
24. Chen X, Yang L, Zhang N et al (2003) Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother 47:2810-2816 (Pubitemid 37040252)
25. Liu DY, Ye JT, Yang WH et al (2004) Ampelosin, a small molecule inhibitor of HIV-1 infection targeting HIV entry. Biomed Environ Sci 17:153-164
26. Paskaleva EE, Lin X, Duus K et al (2008) Sargassum fusiforme fraction is a potent and specific inhibitor of HIV-1 fusion and reverse transcriptase. Virol J 5:8. doi:10.1186/1743-422X-5-8 (Pubitemid 351393327)
27. Neurath AR, Strick N, Li YY et al (2004) Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. BMC Infect Dis 4:41. doi:10.1186/1471-2334-4-41 (Pubitemid 39615387)
28. Zhang Q, Kang X, Yang B et al (2008) Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice. Cancer Biother Radiopharm 23:647-653
29. Shinikai K, Akedo H, Mukai M et al (1996) Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res 87:357-362 (Pubitemid 26147848)
30. Khan A, Greenman J, Archibald SJ (2007) Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates. Curr Med Chem 14:2257-2277 (Pubitemid 47570686)
31. Wu X, Lee VC, Chevalier E (2009) Chemokine receptors as targets for cancer therapy. Curr Pharm Des 15:742-757
32. Hatse S, Princen K, De Clercq E et al (2005) AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. Biochem Pharmacol 70:752-761 (Pubitemid 41058710)
33. 4. Biochem Pharmacol 72:588-596 (Pubitemid 44163295)
34. Liesveld JL, Bechelli J, Rosell K et al (2007) Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells. Leuk Res 31:1553-1563 (Pubitemid 47632788)
35. Liang Z, Wu T, Lou H et al (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64:4302-4308 (Pubitemid 38802437)
36. Kwong J, Kulbe H, Wong D et al (2009) An antagonist of the chemokine recepotor CXCR4 induces mitotic catastrophe in ovarian cancer cells. Mol Cancer Ther 8:1893-1905
37. Jia L, Zhao Y, Liang XJ (2009) Current evaluation of the millennium phytomedicine-ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine. Curr Med Chem 16:2924-2942
38. Lu P, Su W, Miao ZH et al (2008) Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with nonsmall cell lung cancer. Chin J Integr Med 14:33-36 (Pubitemid 351488147)
39. Kou X, Zhang Q, Li X et al (2010) Influences of ginsenoside Rg3 on immune function and fatigue of the postoperative patients with non-small cell lung cancer. Nat Med Front Chin 5:54-55